Latest filing published 15 Jun 2022 for Sana Biotechnology, Inc., €4,883.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
James J. MacDonald: trading record in brief
This profile gathers the share dealings of James J. MacDonald in Sana Biotechnology, Inc., where the filings describe the role as senior executive. The record holds 6 filings, for trades running from 8 February 2021 to 13 June 2022.
The open-market record consists of 1 sale worth €1,840, with no purchase. Outside the open market, there are 2 share grants and 1 option exercise. In 2022 alone, the filings show no purchases and 1 sale.
The newest entry dates from 15 June 2022: an option exercise of €95k, in Sana Biotechnology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to James J. MacDonald
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,183 shares@ US$4.28423.5% of flowCommon StockSEC:0001562180-22-005121:0
- 1,000 shares@ US$18.232576.5% of flowCommon StockSEC:0001562180-22-001784:0
2 of 2 declarations
